106 related articles for article (PubMed ID: 27476332)
1. Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants.
Palma BB; Moutinho D; Urban P; Rueff J; Kranendonk M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Aug; 806():24-33. PubMed ID: 27476332
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression.
Palma BB; Silva E Sousa M; Vosmeer CR; Lastdrager J; Rueff J; Vermeulen NP; Kranendonk M
Pharmacogenomics J; 2010 Dec; 10(6):478-88. PubMed ID: 20125119
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of eight human CYP1A2 variants: the role of cytochrome b5.
Palma BB; Silva E Sousa M; Urban P; Rueff J; Kranendonk M
Pharmacogenet Genomics; 2013 Feb; 23(2):41-52. PubMed ID: 23295917
[TBL] [Abstract][Full Text] [Related]
4. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
5. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
[TBL] [Abstract][Full Text] [Related]
6. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
7. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
[TBL] [Abstract][Full Text] [Related]
8. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
Fasullo M; Smith A; Egner P; Cera C
Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
[TBL] [Abstract][Full Text] [Related]
9. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase.
Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y
Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280
[TBL] [Abstract][Full Text] [Related]
10. Development of a high-throughput genotoxicity assay using Umu test strains expressing human cytochrome P450s and NADPH-P450 reductase and bacterial O-acetyltransferase.
Hori H; Hirata D; Fujii W; Oda Y
Environ Mol Mutagen; 2017 May; 58(4):209-216. PubMed ID: 28436560
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
Anari MR; Josephy PD; Henry T; O'Brien PJ
Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of four allelic variants of human cytochrome P450 1A2.
Zhou H; Josephy PD; Kim D; Guengerich FP
Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
[TBL] [Abstract][Full Text] [Related]
15. Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.
Lewis BC; Korprasertthaworn P; Miners JO
Pharmacogenet Genomics; 2016 Oct; 26(10):453-61. PubMed ID: 27428168
[TBL] [Abstract][Full Text] [Related]
16. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
[TBL] [Abstract][Full Text] [Related]
17. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
Kim D; Guengerich FP
Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
[TBL] [Abstract][Full Text] [Related]
18. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
[TBL] [Abstract][Full Text] [Related]
19. Activation of MeIQ (2-amino-3,4-dimethylimidazo- [4,5-f]quinoline) by sequence variants of recombinant human cytochrome P450 1A2.
Josephy PD; Bibeau KL; Evans DH
Environ Mol Mutagen; 2000; 35(4):328-35. PubMed ID: 10861951
[TBL] [Abstract][Full Text] [Related]
20. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
